Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001567619-21-019299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-03 | 2021-11-01 | TXG | McAnear Justin J. | CFO | S - Sale+OE | $163.54 | -10.0K | 43.6K | -19% | -$1.64M |
| D | 2021-11-03 | 2021-11-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $5.04 | +10.0K | 49.1K | +26% | +$50.4K |
| D | 2021-11-03 | 2021-11-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $0.00 | -10.0K | 370.2K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-01 | S | D | 500 | $162.16 | 48,300 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $161.52 to $162.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-11-01 | S | D | 4,333 | $164.05 | 39,300 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $163.65 to $164.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-11-01 | S | D | 200 | $164.96 | 39,100 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $164.81 to $165.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-11-01 | S | D | 300 | $160.48 | 48,800 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $160.03 to $160.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-11-01 | M | A | 10,000 | $5.04 | 49,100 | D | — | — | |
| 6 | Common | Class A Common Stock | 2021-11-01 | S | D | 4,667 | $163.34 | 43,633 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $162.65 to $163.645. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Derivative | Stock Option (right to buy) | 2021-11-01 | M | D | 10,000 | $0.00 | 370,159 | D | $5.04 · — to 2028-11-02 | 10,000 Class A Common Stock | (F7) This option, originally for 600,000 shares, of which 229,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |